The Impella® Recover mechanical assist device in acute cardiogenic shock: A single-centre experience of 66 patients

Interactive Cardiovascular and Thoracic Surgery

Volumn 22, Issue 4, 2016, Pages 452-458

  Schiller, Petter ^a   Vikholm, Per ^a   Hellgren, Laila ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute cardiogenic shock; Heart failure; Left ventricular assist device

Indexed keywords

LACTIC ACID;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BIOCHEMICAL ANALYSIS; BLEEDING; CARDIOGENIC SHOCK; CENTRAL VENOUS PRESSURE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE FAILURE; DIURESIS; FEMALE; FOLLOW UP; HEART INDEX; HEMODYNAMIC PARAMETERS; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; LEFT VENTRICULAR ASSIST DEVICE; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVOR; TREATMENT DURATION; TREATMENT OUTCOME; CONVALESCENCE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; PATHOPHYSIOLOGY; PROSTHESIS DESIGN; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SHOCK, CARDIOGENIC; SWEDEN; TIME FACTOR;

ACUTE DISEASE; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84965131579     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivv305     Document Type: Article

References (25)

1. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich H-G, Hausleiter J et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-shock II): final 12 month results of a randomised, open-label trial. Lancet 2013;382:1638-45.
2. Lauten A, Engstrom AE, Jung C, Empen K, Erne P, Cook S et al. Percutaneous left ventricular support with the Impella® 2.5 assist device in acute cardiogenic shock-results of the Impella® EUROSHOCK-registry. Circ Heart Fail 2013;6:23-30.
3. Lemaire A, Anderson MB, Lee LY, Scholz P, Prendergast T, Goodman A et al. The Impella® device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg 2014;97:133-8.
4. Griffith BP, Anderson MB, Samuels LE, Pae WE Jr, Naka Y, Frazier OH. The recover I: A multicenter prospective study of Impella® 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg 2013;145:548-54.
5. Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J 2014;35:156-67.
6. Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: Interventional bridge to recovery. Circulation 2012; 125:1809-17.
7. Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007;28:2057-63.
8. Manzo-Silberman S, Fichet J, Mathonnet A, Varenne O, Ricome S, Chaib A et al. Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra aortic blood pump and Impella® recover LP2.5. Resuscitation 2013;84:609-15.
9. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
10. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, De Lemos JA et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:362-425.
11. Thiele H, Sick P, Boudriot E, Diederich K-W, Hambrecht R, Niebauer J et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276-83.
12. Takayama H, Truby L, Koekort M, Uriel N, Colombo P, Mancini D et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 2013;32:106-11.
13. Ouweneel DM, Henriques JP. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart 2012; 98:1246-54.
14. Engstrom AE, Cocchieri R, Driessen AH, Sjauw DK, Vis M, Baan J et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profoun cardiogenic shock: The Academic Medical Center intensive care unit experience. Crit Care Med 2011;39: 2072-9.
15. O'Neill WW, Schreiber T, Wohns DH, Rihal C, Naidu S, Civitello A et al. The current use of Impella® 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella registry. J Interv Cardiol 2014; 27:1-11.
16. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flugel L, Byrne R et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008;52:1584-8.
17. Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W. Initial experiences with the Impella® device in patients with cardiogenic shock- Impella® support for cardiogenic shock. Thorac Cardiovasc Surg 2003;51: 312-7.
18. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC. Importance of venous congestion for worsening of renal function in advanced heart failure. J Am Coll Cardiol 2009;53:589-96.
19. O'Neill WW, Kleiman NS, Moses J, Henriques J, Dixon S, Massaro J et al. A prospective, randomized clinical trial of hemodynamic support with Impella® 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The protect II study. Circulation 2012;126:1717-27.
20. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED et al. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant 2014;33:555-64.
21. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y et al. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function. Circ J 2012;76:1631-8.
22. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the tandemheart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469.e461-468.
23. Matsumiya G, Saitoh S, Sawa Y. Extracorporeal assist circulation for heart failure. Circ J 2009;73(suppl. A):A42-7.
24. Cardarelli MG, Young AJ, Griffith B. Use of extracorporeal membrane oxygenation for adults in cardiac arrest (e-cpr): A meta-analysis of observational studies. ASAIO J 2009;55:581-6.
25. Kawashima D, Gojo S, Nishimura T, Itoda Y, Kitahori K, Motomura N et al. Left ventricular mechanical support with Impella® provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 2011;57:169-76.